CF102
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for CF102, covering 2015-02-27 to 2021-12-29. Get the full timeline:
Most recent: Clinical Trial Update: Phase 2, Randomized, Double-Blind, Placebo-Controlled of the Efficacy and Safety of CF102 in Hepatocellular Carcinoma (HCC) [Phase 2]